| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |